Suppr超能文献

在脓毒性休克中,去甲肾上腺素早期个体化治疗的证据。

Evidence for a personalized early start of norepinephrine in septic shock.

机构信息

AP-HP, Service de Médecine Intensive-Réanimation, Hôpital de Bicêtre, DMU 4 CORREVE, Inserm UMR S_999, FHU SEPSIS, CARMAS, Université Paris-Saclay, 78 rue du Général Leclerc, 94270, Le Kremlin-Bicêtre, France.

Department of Intensive Care Medicine, Fundación Valle del Lili, Av. Simón Bolívar Cra. 98, Cali, Colombia.

出版信息

Crit Care. 2023 Aug 22;27(1):322. doi: 10.1186/s13054-023-04593-5.

Abstract

During septic shock, vasopressor infusion is usually started only after having corrected the hypovolaemic component of circulatory failure, even in the most severe patients. However, earlier administration of norepinephrine, simultaneously with fluid resuscitation, should be considered in some cases. Duration and depth of hypotension strongly worsen outcomes in septic shock patients. However, the response of arterial pressure to volume expansion is inconstant, delayed, and transitory. In the case of profound, life-threatening hypotension, relying only on fluids to restore blood pressure may unduly prolong hypotension and organ hypoperfusion. Conversely, norepinephrine rapidly increases and better stabilizes arterial pressure. By binding venous adrenergic receptors, it transforms part of the unstressed blood volume into stressed blood volume. It increases the mean systemic filling pressure and increases the fluid-induced increase in mean systemic filling pressure, as observed in septic shock patients. This may improve end-organ perfusion, as shown by some animal studies. Two observational studies comparing early vs. later administration of norepinephrine in septic shock patients using a propensity score showed that early administration reduced the administered fluid volume and day-28 mortality. Conversely, in another propensity score-based study, norepinephrine administration within the first hour following shock diagnosis increased day-28 mortality. The only randomized controlled study that compared the early administration of norepinephrine alone to a placebo showed that the early continuous administration of norepinephrine at a fixed dose of 0.05 µg/kg/min, with norepinephrine added in open label, showed that shock control was achieved more often than in the placebo group. The choice of starting norepinephrine administration early should be adapted to the patient's condition. Logically, it should first be addressed to patients with profound hypotension, when the arterial tone is very low, as suggested by a low diastolic blood pressure (e.g. ≤ 40 mmHg), or by a high diastolic shock index (heart rate/diastolic blood pressure) (e.g. ≥ 3). Early administration of norepinephrine should also be considered in patients in whom fluid accumulation is likely to occur or in whom fluid accumulation would be particularly deleterious (in case of acute respiratory distress syndrome or intra-abdominal hypertension for example).

摘要

在脓毒性休克中,血管加压素输注通常仅在纠正循环衰竭的低血容量成分后开始,即使是在最严重的患者中也是如此。然而,在某些情况下,应考虑同时给予去甲肾上腺素和液体复苏来更早地治疗。低血压的持续时间和深度强烈恶化脓毒性休克患者的预后。然而,动脉压对容量复苏的反应是不一致的、延迟的和短暂的。在严重的、危及生命的低血压情况下,仅依靠液体来恢复血压可能会不适当地延长低血压和器官灌注不足的时间。相反,去甲肾上腺素能迅速增加并更好地稳定动脉压。通过结合静脉肾上腺素能受体,它将一部分无应激的血容量转化为应激的血容量。它增加平均全身充盈压,并增加在脓毒性休克患者中观察到的液体诱导的平均全身充盈压增加。这可能改善终末器官灌注,正如一些动物研究所示。两项使用倾向评分比较脓毒性休克患者早期与晚期给予去甲肾上腺素的观察性研究表明,早期给予去甲肾上腺素可减少给予的液体量并降低 28 天死亡率。相反,在另一项基于倾向评分的研究中,休克诊断后 1 小时内给予去甲肾上腺素增加了 28 天死亡率。唯一一项比较早期单独给予去甲肾上腺素与安慰剂的随机对照研究表明,以固定剂量 0.05 µg/kg/min 持续给予早期去甲肾上腺素,并以开放标签的方式添加去甲肾上腺素,与安慰剂组相比,休克控制的实现更为常见。早期开始给予去甲肾上腺素的选择应适应患者的病情。从逻辑上讲,它首先应针对动脉张力非常低的严重低血压患者使用,例如舒张压(例如,≤40mmHg)低或舒张期休克指数(心率/舒张压)(例如,≥3)高。在可能发生液体蓄积或液体蓄积特别有害的患者(例如急性呼吸窘迫综合征或腹腔内高压)中,也应考虑早期给予去甲肾上腺素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3b61/10464210/e28933f8d56c/13054_2023_4593_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验